title: Aripiprazole Once-Monthly is a Cost-Effective Therapeutic Option in the Maintenance Treatment of Schizophrenia: Results from a Markov Model.
authors.affiliation: Lundbeck SAS, Issy les Moulineaux, France.
authors.forename: C
authors.initials: C
authors.lastname: Sapin
authors.affiliation: Pharmerit Ltd, York, UK.
authors.forename: M J
authors.initials: MJ
authors.lastname: Tempest
authors.affiliation: South London and Maudsley NHS Foundation Trust, London, England.
authors.forename: F
authors.initials: F
authors.lastname: Gaughran
authors.affiliation: Lundbeck SAS, Issy les Moulineaux, France.
authors.forename: M
authors.initials: M
authors.lastname: Beillat
authors.affiliation: Otsuka Pharmaceutical Europe Ltd, Wexham, UK.
authors.forename: P
authors.initials: P
authors.lastname: Robinson
authors.affiliation: Pharmerit International, Rotterdam, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Treur